Sign in

    Vadim Alexandre Khalil

    Research Analyst at S.P. Angel

    Vadim Alexandre Khalil is the Head of Healthcare and a Senior Equity Analyst at SP Angel, specializing in small and micro-cap healthcare companies across the UK and international markets. He has provided research coverage and investment insights on firms such as Wellnex Life and Spectral AI, delivering notable calls on discounted capital raises and emerging growth stories in the sector. Joining SP Angel over a decade ago, Vadim has built his career around deep sector expertise, previously gaining experience in finance and equity research before assuming a leadership role at the firm. He is recognized for his nuanced approach to healthcare investing, though specific regulatory credentials or quantitative performance metrics are not publicly disclosed.

    Vadim Alexandre Khalil's questions to Spectral AI (MDAI) leadership

    Vadim Alexandre Khalil's questions to Spectral AI (MDAI) leadership • Q1 2025

    Question

    Asked for details on the development of the company's relationship with the Department of Defense (DoD) and questioned if the DoD contract has the potential to be as significant as the BARDA contract in the future.

    Answer

    The company is actively working to build its relationship with the DoD, similar to its long-standing partnership with BARDA, through the continued development of the Snapshot M device. However, the CFO declined to comment on whether the DoD relationship has the same financial potential as the BARDA contract.

    Ask Fintool Equity Research AI